Q-omics provides the consensus-scored CHEK2P4 profile across patient tissues and cancer cell-line models. CHEK2P4 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in OV. Additionally, CHEK2P4 RNA expression shows 407 significant gene co-expression associations, with the highest sampling consensus in BRCA. Together, these results highlight OV, and BRCA as cancer lineages where CHEK2P4 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.